Bio-Rad Laboratories Inc Class A
BIO: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$684.00 | Yhn | Hgjfxwxlm |
Launching Narrow-Moat Bio-Rad With $360 FVE; Sartorius Stake Gives Firm Intriguing Options
We are launching coverage of diagnostic and life science supplier Bio-Rad with a $360 fair value estimate and narrow, stable moat ratings. We see shares as overvalued, and overexuberance for many diagnostic companies we cover is a trend that has not spared Bio-Rad, and shares are currently trading in 2-star range.